FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Aurobindo Pharma Buyback 2024 and Indus Towers Buyback 2024.
Aurobindo Pharma Buyback 2024 is a Tender Offer buyback proposed to list at BSE, NSE while Indus Towers Buyback 2024 is a Tender Offer proposed to list at BSE, NSE.
Aurobindo Pharma Limited | Indus Towers Limited | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Logo | ![]() |
![]() |
||||||||||||||||||
Type of Buyback | Tender Offer | Tender Offer | ||||||||||||||||||
Listing At | BSE, NSE | BSE, NSE | ||||||||||||||||||
Face Value | ₹1 per share | ₹10 per share | ||||||||||||||||||
Buyback Price | ₹1460 per share | ₹465 per share | ||||||||||||||||||
Issue Size | 51,36,986 shares | 5,67,74,193 shares | ||||||||||||||||||
Issue Size (Amount) | ₹750.00 Crores | ₹2,640.00 Crores | ||||||||||||||||||
Buyback Ratio |
|
|
||||||||||||||||||
Registrar | Kfin Technologies Limited | Kfin Technologies Limited | ||||||||||||||||||
Lead Managers | Axis Capital Limited | Axis Capital Limited | ||||||||||||||||||
Necessity of the buyback | The Buy-Back is being undertaken, inter-alia, for the following reasons:
|
The Buyback is being undertaken, inter-alia, for the following reasons:
|
Aurobindo Pharma Buyback 2024 and Indus Towers Buyback 2024 buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Aurobindo Pharma Buyback 2024 Buyback record date is Jul 30, 2024. Indus Towers Buyback 2024 Buyback record date is Aug 09, 2024.
Aurobindo Pharma Limited | Indus Towers Limited | |
---|---|---|
Record Date | Jul 30, 2024 | Aug 09, 2024 |
Offer Open Date | Aug 05, 2024 | Aug 14, 2024 |
Offer Closure Date | Aug 09, 2024 | Aug 21, 2024 |
Last date for receipt of tender forms | Aug 09, 2024 | Aug 21, 2024 |
Finalisation of buyback | Aug 16, 2024 | Aug 27, 2024 |
Last Date for settlment of bids | Aug 19, 2024 | Aug 28, 2024 |
Last Date for extinguishment of shares | Aug 28, 2024 | Sep 06, 2024 |
Comparison of Aurobindo Pharma Buyback 2024 and Indus Towers Buyback 2024 financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.
Aurobindo Pharma Limited | Indus Towers Limited | ||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Aurobindo Pharma Limited Financial Information (Restated Consolidated)Aurobindo Pharma Limited's revenue increased by 17.55% and profit after tax (PAT) rose by 64.4% between the financial year ending with March 31, 2024 and March 31, 2023.
|
Indus Towers Limited Financial Information (Restated Consolidated)Indus Towers Limited's revenue increased by 0.76% and profit after tax (PAT) rose by 195.89% between the financial year ending with March 31, 2024 and March 31, 2023.
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Stock price at BSE | Stock price at BSE (in preceding 3 months)
|
Stock price at BSE (in preceding 3 months)
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Stock price at NSE | Stock price at NSE (in preceding 3 months)
|
Stock price at NSE (in preceding 3 months)
|
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|